Las Vegas, NV -- (SBWIRE) -- 01/10/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Penn Virginia Corporation(NYSE:PVA), Dendreon Corporation(NASDAQ:DNDN), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), Organovo Holdings Inc(NYSEMKT:ONVO)
Penn Virginia Corporation(NYSE:PVA) was a volume gainer of 5.72 million shares and the average volume of the stock remained 2.63 million shares. The stock opened the session at $11.05 and finished at the end of the day at $10.61 and the stock plunged -3.37% .The market capitalizations of the stock remained 692.75 million. Penn Virginia Corporation, an independent oil and gas company, engages in the exploration and development of natural gas and oil properties in various onshore regions of the United States. The company is involved in the production and sale of natural gas, crude oil, and natural gas liquid products.
Has PVA Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Dendreon Corporation(NASDAQ:DNDN) exchanged 5.62 million shares and the average volume remained 3.56 million shares. The stock closed the session at $2.91 with the gain of 2.11%. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers. Dendreon Corporation was founded in 1992 and is headquartered in Seattle, Washington.
Will DNDN Continue To Move Higher? Find Out Here
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) enhanced 2.36% and its closing price was $6.06. The volume of the stock was 5.43 million shares and the average volume remained 4.18 million shares. The market capitalization of the stock remained 1.32 billion. The beta of the stock remained -0.40. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After The Recent Gain? Just Go Here and Find Out
Organovo Holdings Inc(NYSEMKT:ONVO) exchanged 5.20 million shares in the previous trading session, and its average trading remained 3.88 million shares. ONVO advanced 0.45% and it closed the trading at $11.10. The market capitalization of the stock remained 857.79 million. Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company?s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern.
For How Long ONVO’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)